Publicaciones en colaboración con investigadores/as de GlaxoSmithKline (Spain) (8)

2022

  1. Preventing organ damage in systemic lupus erythematosus: the impact of early biological treatment

    Expert Opinion on Biological Therapy, Vol. 22, Núm. 7, pp. 821-829

2021

  1. Real-world therapeutic management and evolution of patients with benign prostatic hyperplasia in primary care and urology in Spain

    International Journal of Clinical Practice, Vol. 75, Núm. 8

2020

  1. Real-world assessment and characteristics of men with benign prostatic hyperplasia (BPH) in primary care and urology clinics in Spain

    International Journal of Clinical Practice, Vol. 74, Núm. 11

2013

  1. Evaluación económica del tratamiento de la trombocitopenia inmune primaria crónica refractaria con agonistas del receptor de la trombopoyetina

    Farmacia Hospitalaria, Vol. 37, Núm. 3, pp. 182-191

2010

  1. Spray-drying of poly(anhydride) nanoparticles for drug/antigen delivery

    Journal of Drug Delivery Science and Technology, Vol. 20, Núm. 5, pp. 353-359

2009

  1. El síndrome de piernas inquietas: detección, diagnóstico, consecuencias sobre la salud y utilización de recursos sanitarios

    Revista Clinica Espanola, Vol. 209, Núm. 8, pp. 371-381

  2. The Influence of Baseline Parameters on Changes in International Prostate Symptom Score with Dutasteride, Tamsulosin, and Combination Therapy among Men with Symptomatic Benign Prostatic Hyperplasia and an Enlarged Prostate: 2-Year Data from the CombAT Study

    European Urology, Vol. 55, Núm. 2, pp. 461-471

2003

  1. A randomized study comparing lamivudine monotherapy after a short course of hepatitis B immune globulin (HBIg) and lamivudine with long-term lamivudine plus HBIg in the prevention of hepatitis B virus recurrence after liver transplantation

    Journal of Hepatology